The Case for MR-PET in Clinical Routine

More data supports a more accurate diagnosis across diseases

“MR-PET will become the standard of care. It might be three, five, or ten years from now. But it will become the standard of care.” —Robert Day,
Chief Operating Officer and Chief Technical Officer,
Zwanger-Pesiri Radiology

This statement from Robert Day, Chief Operating Officer and Chief Technical Officer at Zwanger-Pesiri Radiology, echoes the growing demand for MR-PET imaging to accurately diagnose and treat patients across various disease states, including Oncology, Neurology, and Cardiology.

Because MR-PET combines MRI’s excellent soft tissue resolution with PET’s ability to detect cellular metabolism into one simultaneous scan, it supports a fast, precise assessment of disease in less time and with less dose compared to PET-CT.

Considered one of the most progressive radiology practices in the U.S., Zwanger-Pesiri remains at the forefront of modern imaging technology by successfully integrating MR-PET imaging into clinical routine. Learn how the practice is using our Biograph mMR scanner to see and treat disease differently.

Download the case study 0.5 MB

The statement by the Siemens customer described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption), there can be no guarantee that other customers will achieve the same results.